Supriyo Bera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Supriyo Bera has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Pinak Chakrabarti
Department of Biochemistry Bose Institute Kolkata India
3 shared publications - Soumyananda Chakraborti
Birla Institute of Technology & Science, Telangana, India
2 shared publications Amit S. Pithadia
Department of Chemistry, University of Michigan, 930 N. University Avenue, Ann Arbor, MI 48109-1055, USA
1 shared publication- Anirban Bhunia
Department of Chemical Sciences, Bose Institute, Unified Academic Campus, Salt Lake, Sector V, Kolkata 700091, India
1 shared publication - Anirban Ghosh
Central European Institute of Technology (CEITEC), Masaryk University , Brno 62500
1 shared publication - Anupam Midya
School of Nanoscience and Technology, Indian Institute of Technology Kharagpur, Kharagpur 721302, India
1 shared publication
Latest Publications
- 1 September 2021
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 708, 108940
Inhibition of microtubule assembly and cytotoxic effect of graphene oxide on human colorectal carcinoma cell HCT116
- 1 September 2021
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 708, 108940
Inhibition of microtubule assembly and cytotoxic effect of graphene oxide on human colorectal carcinoma cell HCT116
- 1 December 2018
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 120, 2390-2398
Molecular features of interaction involving hen egg white lysozyme immobilized on graphene oxide and the effect on activity
- 1 December 2018
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 120, 2390-2398
Molecular features of interaction involving hen egg white lysozyme immobilized on graphene oxide and the effect on activity
- 1 August 2016
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 12 (6) , 1499-1509
The antimicrobial activity of ZnO nanoparticles against Vibrio cholerae : Variation in response depends on biotype
- 1 August 2016
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 12 (6) , 1499-1509
The antimicrobial activity of ZnO nanoparticles against Vibrio cholerae : Variation in response depends on biotype
- 24 March 2015
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 54 (13) , 2249-2261
Self-Assembly of a Nine-Residue Amyloid-Forming Peptide Fragment of SARS Corona Virus E-Protein: Mechanism of Self Aggregation and Amyloid-Inhibition of hIAPP
Molecular self-assembly, a phenomenon widely observed in nature, has been exploited through organic molecules, proteins, DNA, and peptides to study complex biological systems. These self-assembly systems may also be used in understanding the molecular and structural biology which can inspire the design and synthesis of increasingly complex biomaterials. Specifically, use of these building blocks to investigate protein folding and misfolding has been of particular value since it can provide tremendous insights into peptide aggregation related to a variety of protein misfolding diseases, or amyloid diseases (e.g., Alzheimer’s disease, Parkinson’s disease, type-II diabetes). Herein, the self-assembly of TK9, a nine-residue peptide of the extra membrane C-terminal tail of the SARS corona virus envelope, and its variants were characterized through biophysical, spectroscopic, and simulated studies, and it was confirmed that the structure of these peptides influences their aggregation propensity, hence, mimicking amyloid proteins. TK9, which forms a beta-sheet rich fibril, contains a key sequence motif that may be critical for beta-sheet formation, thus making it an interesting system to study amyloid fibrillation. TK9 aggregates were further examined through simulations to evaluate the possible intra- and interpeptide interactions at the molecular level. These self-assembly peptides can also serve as amyloid inhibitors through hydrophobic and electrophilic recognition interactions. Our results show that TK9 inhibits the fibrillation of hIAPP, a 37 amino acid peptide implicated in the pathology of type-II diabetes. Thus, biophysical and NMR experimental results have revealed a molecular level understanding of peptide folding events, as well as the inhibition of amyloid-protein aggregation are reported.
- 24 March 2015
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 54 (13) , 2249-2261
Self-Assembly of a Nine-Residue Amyloid-Forming Peptide Fragment of SARS Corona Virus E-Protein: Mechanism of Self Aggregation and Amyloid-Inhibition of hIAPP
Molecular self-assembly, a phenomenon widely observed in nature, has been exploited through organic molecules, proteins, DNA, and peptides to study complex biological systems. These self-assembly systems may also be used in understanding the molecular and structural biology which can inspire the design and synthesis of increasingly complex biomaterials. Specifically, use of these building blocks to investigate protein folding and misfolding has been of particular value since it can provide tremendous insights into peptide aggregation related to a variety of protein misfolding diseases, or amyloid diseases (e.g., Alzheimer’s disease, Parkinson’s disease, type-II diabetes). Herein, the self-assembly of TK9, a nine-residue peptide of the extra membrane C-terminal tail of the SARS corona virus envelope, and its variants were characterized through biophysical, spectroscopic, and simulated studies, and it was confirmed that the structure of these peptides influences their aggregation propensity, hence, mimicking amyloid proteins. TK9, which forms a beta-sheet rich fibril, contains a key sequence motif that may be critical for beta-sheet formation, thus making it an interesting system to study amyloid fibrillation. TK9 aggregates were further examined through simulations to evaluate the possible intra- and interpeptide interactions at the molecular level. These self-assembly peptides can also serve as amyloid inhibitors through hydrophobic and electrophilic recognition interactions. Our results show that TK9 inhibits the fibrillation of hIAPP, a 37 amino acid peptide implicated in the pathology of type-II diabetes. Thus, biophysical and NMR experimental results have revealed a molecular level understanding of peptide folding events, as well as the inhibition of amyloid-protein aggregation are reported.